As of 2026-05-08, the Relative Valuation of TG Therapeutics Inc (TGTX) is 39.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.03 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -9.0%.
The range of the Relative Valuation is 14.40 - 66.53 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 23.8x | 22.8x |
| Forward P/E multiples | 20.0x - 23.9x | 20.1x |
| Fair Price | 14.40 - 66.53 | 39.15 |
| Upside | -66.5% - 54.6% | -9.0% |
| Date | P/E |
| 2026-05-07 | 15.36 |
| 2026-05-06 | 14.99 |
| 2026-05-05 | 12.89 |
| 2026-05-04 | 12.75 |
| 2026-05-01 | 12.09 |
| 2026-04-30 | 12.06 |
| 2026-04-29 | 11.99 |
| 2026-04-28 | 12.35 |
| 2026-04-27 | 12.63 |
| 2026-04-24 | 13.08 |
| 2026-04-23 | 13.18 |
| 2026-04-22 | 13.68 |
| 2026-04-21 | 12.96 |
| 2026-04-20 | 13.20 |
| 2026-04-17 | 12.62 |
| 2026-04-16 | 12.25 |
| 2026-04-15 | 12.36 |
| 2026-04-14 | 12.34 |
| 2026-04-13 | 12.07 |
| 2026-04-10 | 12.05 |
| 2026-04-09 | 12.37 |
| 2026-04-08 | 12.22 |
| 2026-04-07 | 11.92 |
| 2026-04-06 | 12.03 |
| 2026-04-02 | 11.97 |
| 2026-04-01 | 11.99 |
| 2026-03-31 | 11.86 |
| 2026-03-30 | 11.25 |
| 2026-03-27 | 11.34 |
| 2026-03-26 | 11.42 |
| 2026-03-25 | 11.36 |
| 2026-03-24 | 10.79 |
| 2026-03-23 | 10.87 |
| 2026-03-20 | 10.74 |
| 2026-03-19 | 10.84 |
| 2026-03-18 | 10.73 |
| 2026-03-17 | 11.25 |
| 2026-03-16 | 10.27 |
| 2026-03-13 | 9.98 |
| 2026-03-12 | 9.62 |
| 2026-03-11 | 10.02 |
| 2026-03-10 | 10.45 |
| 2026-03-09 | 10.42 |
| 2026-03-06 | 10.45 |
| 2026-03-05 | 10.37 |
| 2026-03-04 | 10.42 |
| 2026-03-03 | 10.31 |
| 2026-03-02 | 10.50 |
| 2026-02-27 | 10.75 |
| 2026-02-26 | 11.03 |